Dr. Shapiro on Preventative Drugs in Breast Cancer

Charles L. Shapiro, MD
Published Online: Monday, January 27, 2014
Charles L. Shapiro, MD, professor, College of Medicine, The James, Ohio State University Comprehensive Care Center, discusses the underutilization of preventative drugs for breast cancer.

Shapiro says preventative drugs in breast cancer are underutilized. There are many people that are considered high-risk for breast cancer but do not choose to take preventative drugs. Many people have a fear of side effects, Shapiro says, and will not take the risk of having side effects if they are not already diagnosed with cancer.

By increasing awareness of preventative drugs for this disease, Shapiro feels that a larger percentage of people who are at a higher risk for breast cancer would take these drugs.

Online CME Activities
Free CME from PER
B-Cell Malignancies: Novel Agents, Emerging Treatment Strategies, and the Revolution of Care
Community Practice Connections: 15th Annual International Lung Cancer CongressĀ®
Community Practice Connections: 13th Annual International Congress on the Future of Breast CancerĀ®
Highlights From the 13th Annual International Congress on the Future of Breast CancerĀ®
More Reading
$auto_registration$